NASDAQ:PPH VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News $97.74 +0.30 (+0.31%) (As of 11:08 AM ET) Add Compare Share Share Today's Range$97.67▼$97.9950-Day Range$90.59▼$97.4452-Week Range$74.05▼$97.99Volume25,285 shsAverage Volume137,346 shsMarket Capitalization$658.77 millionAssets Under Management$706.04 millionDividend Yield1.57%Net Expense Ratio0.36% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Pharmaceutical ETF alerts: Email Address About VanEck Pharmaceutical ETF (NASDAQ:PPH)The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.Read More PPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PPH ETF News HeadlinesAugust 17, 2024 | americanbankingnews.comShort Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Rises By 27.8%August 14, 2024 | msn.comTeva Pharmaceutical hits a new 52-week highAugust 22, 2024 | Angel Publishing (Ad)What Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.July 18, 2024 | seekingalpha.comPPH: A Strong Fund To Play Big PharmaMay 8, 2024 | msn.comJust Say No to Drugs: 3 Pharma Stocks to AvoidApril 23, 2024 | seekingalpha.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 18, 2024 | theglobeandmail.comCanada’s updated guidance on ESG-related investment fund disclosureApril 3, 2024 | msn.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328August 22, 2024 | Angel Publishing (Ad)What Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.April 1, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328See More Headlines Receive PPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Pharmaceutical ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:PPH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$669.96 million Average Daily Volume$141,351.10 Discount/Premium0.08% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerIMC Options OptionableOptionable Options Volume44 Put Options1 Call Options44 Short Interest2,020,000 shs Miscellaneous Outstanding Shares6,740,000Beta0.72 Creation Unit50,000 Creation Fee$500.00 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Ad Stansberry ResearchMillionaire Investor Warns: “Brace for Apple Collapse”Apple stock has quadrupled over the past five years. But now even Warren Buffett is pulling the plug. The Oracle of Omaha just sold HALF his stake – worth more than $75 billion in the iconic tech company.To watch his fascinating interview which has taken Wall Street by storm, click here. VanEck Pharmaceutical ETF ExpensesTypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.48%0.51%Other Expenses0.01%0.33%0.50%0.39%0.54%Total Expense0.36%0.70%0.70%0.61%0.71%Fee Waiver0.00%-0.45%-0.53%-0.32%-0.58%Net Expense0.36%0.61%0.60%0.54%0.59% VanEck Pharmaceutical ETF (PPH) Holdings & ExposureTop 10 PPH HoldingsEli Lilly and Company(NYSE:LLY)Holding Weight: 11.32%Novo Nordisk A/S(NYSE:NVO)Holding Weight: 8.46%Johnson & Johnson(NYSE:JNJ)Holding Weight: 6.49%AbbVie(NYSE:ABBV)Holding Weight: 6.06%Novartis AG ADRHolding Weight: 5.28%Haleon(NYSE:HLN)Holding Weight: 5.22%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 5.15%AstraZeneca(NASDAQ:AZN)Holding Weight: 5.05%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 4.95%Sanofi(NASDAQ:SNY)Holding Weight: 4.83%PPH Sector ExposurePPH Industry ExposureFull Holdings Details Similar ETFsVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipNorthwestern Mutual Wealth Management Co.Bought 2,694 shares on 8/16/2024Ownership: 2.374%Susquehanna International Group LLPBought 4,700 shares on 8/16/2024Ownership: 0.000%Beck Capital Management LLCBought 317 shares on 8/14/2024Ownership: 0.316%Bank of Montreal CanBought 11,500 shares on 8/14/2024Ownership: 0.224%Thrivent Financial for LutheransBought 175,865 shares on 8/13/2024Ownership: 2.609%View All Institutional Transactions PPH ETF - Frequently Asked Questions How have PPH shares performed this year? VanEck Pharmaceutical ETF's stock was trading at $81.37 on January 1st, 2024. Since then, PPH shares have increased by 20.1% and is now trading at $97.74. View the best growth stocks for 2024 here. What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO? 38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. Who are VanEck Pharmaceutical ETF's major shareholders? Top institutional shareholders of VanEck Pharmaceutical ETF include SG Americas Securities LLC, Thrivent Financial for Lutherans (2.61%), Northwestern Mutual Wealth Management Co. (2.37%) and Prime Capital Investment Advisors LLC (1.99%). How do I buy shares of VanEck Pharmaceutical ETF? Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Pharmaceutical ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK) and Applied Materials (AMAT). This page (NASDAQ:PPH) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredMillionaire Investor Warns: “Brace for Apple Collapse”Apple stock has quadrupled over the past five years. But now even Warren Buffett is pulling the plug. The O...Stansberry Research | SponsoredMassive Crypto Selloff = Historic OpportunityStocks recently suffered the worst 1-day loss since 2022… Cryptos got hammered as well…But here's the fact ...Crypto 101 Media | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
